FISCHER MEDICAL VENTURES LTD.
NSE : NABSE : 524743ISIN
CODE : INE771F01025Industry : ChemicalsHouse
: Private
BSE539.7517.8 (+3.41 % )
PREV CLOSE (Rs.) 521.95
OPEN PRICE (Rs.) 498.55
BID PRICE (QTY) 505.55 (1 )
OFFER PRICE (QTY) 538.65 (10 )
VOLUME 74
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 30-Apr-2024 | 04-May-2024 | Inter alia, to consider and approve:- 1. The Change in management of the Company subsequent to completion of open offer in accordance with the provisions of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011; 2. The setting up of corporate office Address of the Company in Chennai, Tamil Nadu; and 3. To transact other incidental and ancillary matters as may be decided by the board |
| 05-Feb-2024 | 12-Feb-2024 | Quarterly Results |
| 12-Dec-2023 | 15-Dec-2023 | Inter alia, to consider and approve: 1. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 2. To transact other incidental and ancillary matters as may be decided by the board. |
| 25-Oct-2023 | 01-Nov-2023 | Quarterly Results |
| 02-Aug-2023 | 12-Aug-2023 | Quarterly Results |
| 23-May-2023 | 29-May-2023 | Quarterly Results |
| 28-Mar-2023 | 30-Mar-2023 | Preferential Issue of shares |
| 06-Feb-2023 | 14-Feb-2023 | Quarterly Results |
| 31-Jan-2023 | 03-Feb-2023 | Inter alia, to consider and approve:- 1. The appointment of Non-Executive Independent Women Director, subject to necessary approval of shareholders. 2. The appointment of Non-Executive Independent Director, subject to necessary approval of shareholders. 3. The appointment of Executive Director subject to necessary approval of shareholders. 4. The appointment of Chief Financial Officer, Key Managerial Personnel. 5. Approve the appointment of Internal Auditor of the Company. 6. Approve the request for reclassification in accordance with Regulation 31A of the SEBI LODR Regulations received from Shri. Sankaranarayanan G M subject to approval of the shareholders and the Stock Exchanges. 7. Any other business with the permission of chairperson |
| 11-Nov-2022 | 17-Nov-2022 | Quarterly Results |
